In this module, we will highlight clinical practice guidelines and will explore, at class level, conventional and advanced treatments for IBD. We will also review the concept of therapeutic drug monitoring (TDM) when caring for patients with IBD.
IBD Treatment Landscape
Topic outline
-
IBD Treatment Landscape
-
In this chapter, we’ll explore the classes of conventional treatments available when caring for patients with IBD, focusing specifically on aminosalicylates, corticosteroids, and immunomodulators. We will also explain how these came to be a part of the practitioner’s tool kit for disease management.
Presented by Kimberly Kearns, MS, APN-BC
-
In this chapter, you will receive a comprehensive review of advanced monitoring techniques, including therapeutic drug monitoring (TDM), for managing biologic therapy. This presentation also includes an analysis of advanced personalized medicine approaches in IBD treatment, including assessing biomarkers and genetics.
Presented by Andres J. Yarur, MD
-
-
Here you will find quick links to a few of the clinical practice guidelines for the management of Crohn’s disease (CD) from US-based medical associations.
ACG Clinical Guideline: Management of Crohn’s Disease in Adults (2018)
-
Here you will find quick links to a few of the clinical practice guidelines for the management of ulcerative colitis (UC) from US-based medical associations.
ACG Clinical Guideline: Ulcerative Colitis in Adults (2019)
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis (2019)
AGA’s Mild-to-Moderate Clinical Decision Support Tool (2019)
AGA Living Guideline for Moderate-to-Severe Ulcerative Colitis (overview with additional resources)
AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis (2020)
-
When it comes to IBD, there’s a lot to cover, and we’ve only begun to scratch the surface. We’re always working on new educational content to help you stay ahead of the curve, so check back often.